InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the complete record of transactions filed by Benedicto David C., Chief Financial Officer. Director active across 1 companies, notably Adamis Pharmaceuticals Corp. In total, 3 reports have been published. Total volume traded: €21k. The latest transaction was disclosed on 18 March 2022 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
€1,9893,603 shares@ €0.55219.6% of flow
Common Stock
SEC:0001387131-22-003860:0·
€9,39113,554 shares@ €0.6928100.0% of flow
Common Stock
SEC:0001387131-21-011778·
€9,39113,554 shares@ €0.692845.2% of flow
Common Stock
SEC:0001387131-21-011778:0·
3 of 3 declarations
About Benedicto David C.
Benedicto David C. is the Chief Financial Officer at Adamis Pharmaceuticals Corp. He is responsible for the company's financial management, including budgeting and performance analysis, playing a key role in financial strategy.
